Earlier this month, Indiana University announced a major commitment to research in one of healthcare’s most promising fields, personalized medicine. The Indiana Institute for Personalized Medicine will pursue genome-based and pharmacogenomics studies in cardiology, pediatrics, obstetrics and cancer, as well as other areas . The emergence of personalized medicine, which targets individualized treatment and care based on personal and genetic variation, is creating a thriving market. Indeed, the market for personalized medicine in the United States is $232 billion and is projected to grow 11% annually .
It is old news that aspirin is good for your heart. But a recent report published in The Lancet, the premiere medical journal in the United Kingdom, claims that at least 75mg of aspirin every day can also reduce the risk of developing many different types of cancers.
There is already evidence that taking aspirin every day for five years can reduce the risk of colorectal cancer. Moreover, aspirin has been shown to reduce the incidence and/or growth rate of a number of cancers in animal models. To determine if aspirin can reduce the risk of other cancers in humans, Peter Rothwell and colleagues at the University of Oxford undertook a meta-analysis of eight randomized trials originally performed to study aspirin’s role in preventing vascular events. This study was independent of any commercial interests.
This article was written by Liz Hodge.
Most of us like a great steak, but may not want to think about how it arrives on our plate. Similarly, we want medicines, vaccines, antibiotics, surgery and diagnostic tools when we’re sick, but we may not care to know how exactly these treatments make it into our hospitals and pharmacies. Well, chances are, scientists developed them with the help of laboratory animals. Nearly every medical breakthrough involves animal research. From antibiotics to blood transfusions, dialysis to organ transplantation, vaccinations to chemotherapy, bypass surgery and joint replacement, practically every drug, treatment, medical device, diagnostic tool or cure we have today was developed with the help of laboratory animals. Each day, dedicated scientists study animals to find new cures for diseases and conditions that are currently incurable.
Highlight HEALTH will be hosting the next edition of the Cancer Research Blog Carnival, edition #38, on Friday, October 1st. As host, I invite you to send your submissions.
October is National Breast Cancer Awareness Month. Accordingly, the theme for next month’s edition of the Cancer Research Blog Carnival is Breast Cancer.
Twenty five years ago in 1985, the pharmaceutical company AstraZeneca founded National Breast Cancer Awareness Month. The aim is to promote mammography as the most effective weapon in the fight against breast cancer.
Have you ever heard a person in poor health being told “Well, you’ve got to stay positive, that will help”? This seemingly common idea is currently under significant scientific investigation. Indeed, the debate about the degree to which psychological processes can directly influence physical health has received special attention recently. A special supplement of the Annals of Behavioural Medicine directly addressed this topic in February this year and a recent article in the Lancet explored this issue, cautioning us that the relationship between a positive psychological orientation and cancer survival remains unclear .